Updates Full Year 2025 Financial GuidanceRADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025. Third Quarter Highlights: Revenue was $104.6 million, compared to$94.8 million in the third quarter of 2024, representing growth of 10%. Software revenue was $43.8 million, compared to$35.9 million in the third quarter of 2024, representing growth of 22%.Servi ...